Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04931693
Other study ID # MS-316-2020
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date December 20, 2021
Est. completion date August 20, 2022

Study information

Verified date October 2022
Source Kasr El Aini Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluation of Ultrasound Guided Modified Pectoral Nerves Blocks in Transvenous Subpectoral pacemaker insertion in Children: Randomized Controlled Trial


Description:

BACKGROUND Pectoral nerve blocks (PECs) can reduce intraprocedural anesthetic requirements and postoperative pain. Little is known about the utility of PECs in reducing pain and narcotic use after pacemaker (PM)placement in children. OBJECTIVE The purpose of this study was to determine whether PECs can decrease postoperative pain and opioid use after PM placement in children. METHODS A single-center controlled trial of pediatric patients undergoing transvenous PM placement between 2020 and 2021 will be performed. Demographics, procedural variables, postoperative pain, and postoperative opioid usage will be compared between patients who undergone PECs and those who undergone conventional anesthetic (Control).


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 20, 2022
Est. primary completion date June 20, 2022
Accepts healthy volunteers No
Gender All
Age group 1 Year to 9 Years
Eligibility Inclusion Criteria: - congenital or post-operative heart block. Exclusion Criteria: - ? Redo patient - History of allergic reactions to local anesthetics. - Bleeding disorders with International Normalization Ratio( INR) > 1.5 and/or platelets < 50 000. - Rash or signs of infection at the injection site. - Emergency procedure

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
paracetamol
iv post operative analgesia
Procedure:
modifiedPECs block
sonar guided pectoral nerve block

Locations

Country Name City State
Egypt Kasr Al Ainy Hospital Cairo

Sponsors (1)

Lead Sponsor Collaborator
Kasr El Aini Hospital

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Anderson R, Harukuni I, Sera V. Anesthetic considerations for electrophysiologic procedures. Anesthesiol Clin. 2013 Jun;31(2):479-89. doi: 10.1016/j.anclin.2013.01.005. Epub 2013 Feb 23. Review. — View Citation

Yang JK, Char DS, Motonaga KS, Navaratnam M, Dubin AM, Trela A, Hanisch DG, McFadyen G, Chubb H, Goodyer WR, Ceresnak SR. Pectoral nerve blocks decrease postoperative pain and opioid use after pacemaker or implantable cardioverter-defibrillator placement — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Post-operative pain score by The Face, Legs, Activity, Cry, Consolability scale (FLACC) scale. pain score immediate, 6,12 ,18 and 24 hours after intervention
Secondary Total consumption of opioids. morphine dose immediate, 6,12 ,18 and 24 hours after intervention
See also
  Status Clinical Trial Phase
Completed NCT04245345 - Accelerometer Sensing for Micra AV Study N/A
Completed NCT00374608 - Exercise in Chronically Paced Children N/A
Recruiting NCT05541679 - Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE) N/A
Not yet recruiting NCT05666219 - Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients Phase 4
Completed NCT02809131 - Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections. Phase 3